Sinonasal melanoma (SMM) is a rare but aggressive malignancy with 5‐year overall survival (OS) rates below 40% in published studies. However, the clinicopathological predictors of the prognosis of SMM remain… Click to show full abstract
Sinonasal melanoma (SMM) is a rare but aggressive malignancy with 5‐year overall survival (OS) rates below 40% in published studies. However, the clinicopathological predictors of the prognosis of SMM remain undefined. We aimed to establish a model to predict the survival outcomes of SMM.
               
Click one of the above tabs to view related content.